KELLY THELEN: Open Payments
NPI 1619071206 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 32 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $911 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $188 |
| ABBVIE INC. | 5 | $171 |
| Xeris Pharmaceuticals, Inc. | 7 | $135 |
| Lilly USA, LLC | 5 | $92 |
| HARMONY BIOSCIENCES LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Phadia US Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Auvelity, QULIPTA, RECORLEV, JARDIANCE, MOUNJARO, WAKIX, HETLIOZ, ImmunoCAP.
Industry payments across NE — which companies pay providers there.
